Quarterly report pursuant to Section 13 or 15(d)

Equity (Details Textual)

v3.7.0.1
Equity (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
May 15, 2017
Jan. 13, 2017
Feb. 21, 2017
Feb. 14, 2017
Apr. 22, 2016
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Feb. 09, 2017
May 02, 2016
Class of Stock [Line Items]                    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options           $ 1,490,000        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date         Dec. 05, 2025          
Common Stock, Shares Authorized           75,000,000   75,000,000   75,000,000
Share-based Compensation, Total           $ 110,000 $ 2,000      
Shares Issued, Price Per Share           $ 1.35        
Proceeds from Issuance Initial Public Offering $ 1,240,000         $ 4,460,000 $ 387,000      
Shares Authorized                   80,000,000
Preferred Stock, Shares Authorized           5,000,000   5,000,000   5,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross           20,000   460,000    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price           $ 2.31   $ 5.83    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition           3 years 3 months 11 days        
Estimated Forfeiture Rate Percentage           0.00%        
Accounts Payable and Accrued Liabilities, Current, Total           $ 858,000   $ 1,069,000    
Maximum [Member]                    
Class of Stock [Line Items]                    
Shares Issued, Price Per Share                 $ 1.50  
Minimum [Member]                    
Class of Stock [Line Items]                    
Shares Issued, Price Per Share                 $ 1.35  
Former Science Advisory Board [Member]                    
Class of Stock [Line Items]                    
Stock Issued During Period, Shares, Issued for Services   79,167                
Gain Loss on Noncash Settlement of Liability     $ 150,000              
Accounts Payable and Accrued Liabilities, Current, Total               $ 240,000    
IPO [Member]                    
Class of Stock [Line Items]                    
Shares Issued, Price Per Share       $ 1.35            
Proceeds from Issuance Initial Public Offering       $ 4,460,000            
Number Of Units issued       3,923,923            
2015 Stock Plan [Member]                    
Class of Stock [Line Items]                    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant         2,500,000          
Science Advisory Board [Member]                    
Class of Stock [Line Items]                    
Share-based Compensation, Total           $ 110,000        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross           20,000        
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price           $ 2.31        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period           10 years        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period           4 years        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value           $ 35,196        
Science Advisory Board [Member] | Maximum [Member]                    
Class of Stock [Line Items]                    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions           2.24%        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term           6 years 3 months        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate           89.11%        
Science Advisory Board [Member] | Minimum [Member]                    
Class of Stock [Line Items]                    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions           1.30%        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term           6 years        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate           70.18%